Agustín Ruiz Selected Research

calpain 10

1/2011	Calpain 10 gene and laryngeal cancer: a survival analysis.
8/2008	The CAPN10 gene is associated with insulin resistance phenotypes in the Spanish population.
1/2007	Calpain-5 gene variants are associated with diastolic blood pressure and cholesterol levels.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Agustín Ruiz Research Topics

Disease

35	Alzheimer Disease (Alzheimer's Disease) 06/2022 - 07/2011
17	Cognitive Dysfunction 06/2022 - 01/2013
13	Dementia (Dementias) 06/2022 - 01/2013
3	Inflammation (Inflammations) 01/2022 - 06/2010
3	Infections 01/2020 - 04/2011
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2018 - 02/2016
3	Frontotemporal Dementia (Semantic Dementia) 01/2018 - 01/2017
3	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2015 - 12/2012
2	Disease Progression 01/2022 - 04/2021
2	COVID-19 12/2021 - 01/2020
2	Genetic Risk Score 01/2021 - 01/2016
2	Insulin Resistance 04/2011 - 08/2008
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2010 - 08/2008
2	Infertility (Sterility) 08/2008 - 08/2005
2	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 08/2008 - 01/2007
2	Obesity 07/2008 - 01/2007
2	Osteoporosis 07/2007 - 07/2006
2	Ovarian Hyperstimulation Syndrome 07/2006 - 09/2005
1	Tauopathies 05/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	Brain Hypoxia (Cerebral Hypoxia) 01/2020
1	Parkinson Disease (Parkinson's Disease) 01/2020
1	Ganglion Cysts (Ganglion) 01/2020
1	Amyloidosis 12/2019
1	Memory Disorders (Memory Loss) 01/2018
1	Disease Susceptibility (Diathesis) 09/2014
1	Multiple Sclerosis 01/2012
1	Chronic Hepatitis C 04/2011
1	Meningitis 03/2011
1	Laryngeal Neoplasms (Laryngeal Cancer) 01/2011
1	Hepatic Encephalopathy 09/2010
1	Fibrosis (Cirrhosis) 09/2010
1	Corneal Ulcer 06/2010
1	Corneal Perforation 06/2010
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 06/2010
1	Type 2 Diabetes Mellitus (MODY) 08/2008
1	Anovulation 08/2008
1	Autoimmune Diseases (Autoimmune Disease) 07/2007
1	Essential Hypertension 07/2007
1	Breast Neoplasms (Breast Cancer) 07/2007

Drug/Important Bio-Agent (IBA)

20	Apolipoproteins E (ApoE)IBA 01/2022 - 12/2012
18	Biomarkers (Surrogate Marker)IBA 06/2022 - 01/2013
8	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2014
6	Proteins (Proteins, Gene)FDA Link 05/2022 - 07/2007
5	ApolipoproteinsIBA 01/2021 - 01/2016
3	Amyloid beta-PeptidesIBA 01/2021 - 01/2013
3	Retinaldehyde (Retinal)IBA 01/2020 - 11/2018
3	LipidsIBA 01/2019 - 01/2007
3	Glucose (Dextrose)FDA LinkGeneric 04/2011 - 01/2007
3	calpain 10IBA 01/2011 - 01/2007
2	Genetic Markers (Genetic Marker)IBA 01/2019 - 08/2008
2	Phosphotransferases (Kinase)IBA 01/2018 - 01/2017
2	Estrogen Receptor alphaIBA 01/2012 - 07/2006
2	Insulin (Novolin)FDA Link 04/2011 - 01/2007
2	Estrogens (Estrogen)FDA Link 07/2007 - 07/2006
1	Mitochondrial DNA (mtDNA)IBA 03/2022
1	ApoferritinsIBA 01/2022
1	antineoplaston A10 (A 10)IBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Matrix Metalloproteinase 10 (Stromelysin 2)IBA 01/2022
1	sharpinIBA 01/2021
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2021
1	LysophospholipidsIBA 10/2020
1	Phospholipids (Phosphatides)FDA LinkGeneric 10/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	ethyl 4-azidophenyl-1,4-dithiobutyrimidateIBA 01/2020
1	Hypnotics and Sedatives (Sedatives)IBA 01/2020
1	Biological ProductsIBA 10/2019
1	sortilinIBA 01/2018
1	VaccinesIBA 01/2018
1	Peptides (Polypeptides)IBA 01/2018
1	AlbuminsIBA 01/2018
1	TubulinIBA 02/2016
1	Protein Isoforms (Isoforms)IBA 01/2015
1	NeuroliginsIBA 01/2013
1	PresenilinsIBA 01/2013
1	HLA-DRB1 Chains (HLA DRB1)IBA 01/2012
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2012
1	P-2 (P 2)IBA 07/2011
1	Complement Receptors (Complement Receptor)IBA 07/2011
1	urotensin IIIBA 04/2011
1	Antiviral Agents (Antivirals)IBA 04/2011
1	Adenosine DeaminaseIBA 03/2011
1	Triglycerides (Triacylglycerol)IBA 10/2010
1	GlutaminaseIBA 09/2010
1	Chloride Channels (Chloride Channel)IBA 09/2010
1	Rituximab (Mabthera)FDA Link 06/2010
1	CholesterolIBA 08/2008
1	CalpainIBA 07/2008
1	PPAR gammaIBA 07/2008
1	PPAR deltaIBA 07/2008
1	AntibodiesIBA 07/2007
1	AntigensIBA 07/2007

Therapy/Procedure

4	Therapeutics 01/2022 - 12/2019
1	Artificial Respiration (Mechanical Ventilation) 01/2020
1	Cognitive Training 01/2020
1	Long-Term Care 01/2020
1	Immunotherapy 01/2018
1	Secondary Prevention 01/2014
1	Liver Transplantation 09/2010